Where does Converge Bio's cap table come from?

Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Converge Bio's 1 recorded funding rounds.

Premier Alternatives

Converge Bio

Other Information Technology · Wilmington, DE · Founded 2024 · Privately Held (backing)

Developer of a biotech platform designed to apply generative artificial intelligence to biological data for advancing drug discovery and development. Converge Bio is based in Wilmington, DE and was founded in 2024. It was valued at $90 million at its early-stage round in Jan 2026, the last priced event on record. It has raised $30.5 million across 1 recorded round; the latest was a $25 million Series A in Jan 2026.

PMV mark · valuation

$90.0M

Oct 2026

Priced at

its early-stage round

Jan 2026

Total raised

$30.5M

Last round

Early Stage VC (Series A)

Jan 2026

Cap table — not yet on record

Converge Bio's share-class structure hasn't surfaced in our sources yet. Cap tables are assembled from certificates of incorporation, round filings, and disclosures as they land.

Pro members can request priority coverage with a 48-hour turnaround.

Free account

More of Converge Bio with a free account

·Watch Converge Bio: the Monday email on marks, rounds and moves

Create free account

No card required

Membership and data by Private Market View

Frequently asked about Converge Bio

Where does Converge Bio's cap table come from?: Share classes are assembled from certificates of incorporation, priced-round filings, and disclosures across Converge Bio's 1 recorded funding rounds.